about
Micro spies from the brain to the periphery: new clues from studies on microRNAs in neuropsychiatric disordersEmerging role of non-coding RNA in neural plasticity, cognitive function, and neuropsychiatric disordersEpigenetics of Aging and Alzheimer's Disease: Implications for Pharmacogenomics and Drug ResponseInsect microRNAs: biogenesis, expression profiling and biological functionsAntisense oligonucleotides: treating neurodegeneration at the level of RNAMicroRNAs as biomarkers for CNS diseaseThe interplay between microRNAs and histone deacetylases in neurological diseasesConsolidation and translation regulationNeurobehavioral Alterations in a Genetic Murine Model of Feingold Syndrome 2Early mechanisms of pathobiology are revealed by transcriptional temporal dynamics in hippocampal CA1 neurons of prion infected miceExploring Biomarkers for Alzheimer's DiseaseGetting miRNA Therapeutics into the Target Cells for Neurodegenerative Diseases: A Mini-ReviewNIH workshop report on the trans-agency blood-brain interface workshop 2016: exploring key challenges and opportunities associated with the blood, brain and their interface.Amygdala-dependent fear memory consolidation via miR-34a and Notch signaling.Revisiting adult neurogenesis and the role of erythropoietin for neuronal and oligodendroglial differentiation in the hippocampusProfiles of extracellular miRNA in cerebrospinal fluid and serum from patients with Alzheimer's and Parkinson's diseases correlate with disease status and features of pathologyMicroRNAs: new insights into the pathogenesis of endodontic periapical disease.Widespread microRNA dysregulation in multiple system atrophy - disease-related alteration in miR-96.RNA metabolism in neurodegenerative disease.Hypoxia induces downregulation of soluble guanylyl cyclase β1 by miR-34c-5pEpigenetic mechanisms during ageing and neurogenesis as novel therapeutic avenues in human brain disorders.Prediction of miRNA-mRNA associations in Alzheimer's disease mice using network topology.Adult-specific functions of animal microRNAs.Epigenetic memory: the Lamarckian brainmiRNAs at the interface of cellular stress and diseaseMicroRNA-125b induces tau hyperphosphorylation and cognitive deficits in Alzheimer's diseaseK-Lysine acetyltransferase 2a regulates a hippocampal gene expression network linked to memory formationTemporal profiling of gene networks associated with the late phase of long-term potentiation in vivo.MicroRNA-122 down-regulation is involved in phenobarbital-mediated activation of the constitutive androstane receptor.MicroRNAs as the cause of schizophrenia in 22q11.2 deletion carriers, and possible implications for idiopathic disease: a mini-review.Genetic variation in hippocampal microRNA expression differences in C57BL/6 J X DBA/2 J (BXD) recombinant inbred mouse strainsThe epigenetic dimension of Alzheimer's disease: causal, consequence, or curiosity?miRNA regulons associated with synaptic function.Nutrigenomics of extra-virgin olive oil: A review.Rapid regulation of microRNA following induction of long-term potentiation in vivoThe emerging role of microRNAs in Alzheimer's disease.Studying the system-level involvement of microRNAs in Parkinson's diseaseA network of RNA and protein interactions in Fronto Temporal Dementia.Releasing a tiny molecular brake may improve memory.miR-26a and miR-384-5p are required for LTP maintenance and spine enlargement.
P2860
Q21129476-03CE18B2-54E9-4A67-93C2-DF2145132369Q21558421-82384AC1-407A-453B-BECF-6298CECCE5A3Q26772028-57A9D6D0-BB12-44F8-8D69-DBBF346777F0Q26829772-3063DBAD-5E83-4E1E-85B4-5E55DC18C228Q27007056-2807418A-6386-404C-89FB-B44EF7D57CF0Q27013998-1D42A081-144A-4244-8B10-DCDFE973F04EQ27024466-E6522F6F-7917-4967-AC0A-CF342B41CD20Q27025904-85D6BC24-AE19-4929-83E2-8C2A76D9A316Q27317675-00532570-5B79-48F9-84CE-58E67F4764EFQ27340506-9B768C06-3B67-4777-8A7E-04250A25BE44Q28079218-B71639FB-3180-4CFD-88DC-BB10CBE6F835Q28079707-C7474607-293B-4932-9D07-6EF1EEF9F3AEQ30352890-17FE5007-C497-4A40-9369-265EBF616292Q30587469-0E7C57AE-79B6-44B4-AC14-4267F09A1567Q30833366-2FD285AF-C662-4FE1-BE4D-C4AF3088A31AQ33567669-7CC9519C-3C15-4800-9091-2CC9DE45956AQ33640951-9C82A529-E7B8-4905-81AD-63A5E1CD0770Q33738316-CAF5EF36-554D-4DA8-8821-81A0053B58BAQ33746283-E0CBB465-27DC-456B-80C8-979073D8EFBCQ33818129-327F33EA-3830-49C7-B6BA-9ADF820ADED5Q33858861-6E4A302D-B093-4EAB-8C50-5210CEDA8E4CQ34045195-3D222627-83D5-48CE-A318-354420CE545DQ34061489-5B2A46D2-3D88-43A5-93D2-84776E5E2795Q34323841-9CBAF8C0-7E49-477F-B7D9-A9DF56B44794Q34324509-95176E17-492C-46E5-AC98-CABC4CD4CCC4Q34324544-041BE40B-0BCF-4D9F-9CDF-5000FCB682F5Q34332494-9C9031D6-89E2-4ABE-A904-C7CA38B05235Q34339730-8EBB80C1-F386-4F03-8106-059F2AF976A6Q34345924-729E9C6A-073C-4E47-90CA-E2E671AC1741Q34394249-B07E2C5F-B21C-4689-AF57-57A51BC56BC3Q34413899-FA69B2B9-640E-426B-A6EE-FB8975252306Q34426210-85484E6F-E778-490E-B278-9F4E99E921FFQ34446986-DEB79F51-774B-4B8B-9223-C36F06C694D3Q34539068-9B2169CE-C1B1-4DF5-855A-AFDB519CD02BQ34660735-19CF2DE4-3339-45FE-8EF7-C893AA6926D3Q35076344-2CB28040-60EC-4824-8D5A-5AF2717B300FQ35137389-9FB8163A-FF13-4D0F-B877-9A26BD81CF15Q35194634-8F7F279B-CF37-4642-9CB3-B6AC23B5DBFDQ35422454-3F28FC9F-F30F-4B9B-9F23-A191A9F3278EQ35487610-409800F3-39B3-43E2-B825-2D635835B219
P2860
description
2011 nî lūn-bûn
@nan
2011 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
microRNA-34c is a novel target to treat dementias
@ast
microRNA-34c is a novel target to treat dementias
@en
type
label
microRNA-34c is a novel target to treat dementias
@ast
microRNA-34c is a novel target to treat dementias
@en
prefLabel
microRNA-34c is a novel target to treat dementias
@ast
microRNA-34c is a novel target to treat dementias
@en
P2093
P2860
P50
P356
P1433
P1476
microRNA-34c is a novel target to treat dementias
@en
P2093
Andre Fischer
Athanasios Zovoilis
Farahnaz Sananbenesi
Hope Y Agbemenyah
Laurent Farinelli
Roberto C Agis-Balboa
Sanaz Bahari-Javan
Susanne Burkhardt
P2860
P304
P356
10.1038/EMBOJ.2011.327
P407
P577
2011-09-23T00:00:00Z